Atai Life Sciences Cash on Hand 2020-2024 | ATAI
Atai Life Sciences cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Atai Life Sciences Annual Cash on Hand
(Millions of US $) |
| 2023 |
$179 |
| 2022 |
$273 |
| 2021 |
$362 |
| 2020 |
$97 |
| 2019 |
$30 |
Atai Life Sciences Quarterly Cash on Hand
(Millions of US $) |
| 2024-09-30 |
$101 |
| 2024-06-30 |
$103 |
| 2024-03-31 |
$111 |
| 2023-12-31 |
$179 |
| 2023-09-30 |
$209 |
| 2023-06-30 |
$227 |
| 2023-03-31 |
$250 |
| 2022-12-31 |
$273 |
| 2022-09-30 |
$304 |
| 2022-06-30 |
$312 |
| 2022-03-31 |
$124 |
| 2021-12-31 |
$362 |
| 2021-09-30 |
$430 |
| 2021-06-30 |
$454 |
| 2021-03-31 |
$104 |
| 2020-12-31 |
$97 |
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
$30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.305B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
